Business Context and Reporting Period
This Form 8-K Current Report was filed by IRIDEX Corporation on July 28, 2018. The report discloses compensatory arrangements approved by the Board of Directors for Named Executive Officers under the Company's 2008 Equity Incentive Plan.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation details.
Material Changes
The material event reported is the approval of new equity grants for the President and Chief Executive Officer (William M. Moore) and the Chief Financial Officer (Atabak Mokari). No financial performance changes are detailed in this specific filing.
Guidance, Outlook, and Management Commentary
The filing outlines the terms of the equity grants:
- Restricted Stock Units (RSUs): Mr. Moore received 40,000 RSUs and Mr. Mokari received 16,800 RSUs. These vest in three equal tranches on July 27 of 2019, 2020, and 2021, contingent on continued service.
- Performance-Based RSUs (PRSUs): Mr. Moore received a target of 60,000 PRSUs and Mr. Mokari received a target of 25,200 PRSUs.
- Performance Metrics: PRSU vesting is tied to revenue, product release, and relative shareholder return metrics over one, two, and three-year periods.
- Vesting Schedule: Upon meeting performance criteria, 50% of eligible PRSUs vest immediately, with the remaining 50% vesting one year later.
- Maximum Payout: Up to 114.75% of the target share count may vest based on maximum achievement of performance criteria.
Investor Verification Checklist
- Verify the specific revenue and product release targets defined for the PRSU performance periods.
- Confirm the Company's relative shareholder return benchmark and peer group selection.
- Review the 2008 Equity Incentive Plan to ensure sufficient shares remain available for these grants.
- Monitor future filings for the actual vesting outcomes of the 2019, 2020, and 2021 tranches.